Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
SKRR to Commence Uranium Drill Program to Test Conductors at Clearwater West (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Healthcare Drug Manufacturers - Major Cannabis
Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Aphria Inc.
Bullboard Posts
User Avatar Image
(337)
•••
Comment by jayjay2020on Sep 15, 2019 5:42pm
151 Views
Post# 30128897

RE:RE:Who will buy Aphas 255000 kgs of weed in 2020

RE:RE:Who will buy Aphas 255000 kgs of weed in 2020
Thewanderer wrote:
YukonJer wrote:
???

First of all they don’t have to sell ALL 255k next year for them to grow, be profitable  and for the stock to have massive upside. Second off all, eventually theyy WILL sell  all 255k and who will buy it? 
The answer lies in the link below and the number is rising and rising. 
You are really short sighted man. 
https://www.worldometers.info/world-population/


EU GMP certification is just as important as DD licensing. CC Pharma has a huge customer base. EU GMP will allow APHA to immediately export to Germany. The 225 000 kg will be quickly used up.
Bullboard Posts
Dealroom for high-potential pre-IPO opportunities